Trial Profile
A clinical trial of Oradoxel - an oral form of docetaxel
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Feb 2016 New trial record